Patent · US Active

Treatment of muscular disorders with combinations of RXR agonists and thyroid hormones

US10835507B2 · kind B2 · utility

11Cited by
66References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2016
Grant dateNov 17, 2020
Priority date—
Expiry dateOct 31, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present specification provides methods of treating a muscular disorder with a combination of a RXR agonist and a thyroid hormone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.